NCT06453681View on ClinicalTrials.gov

Dexmedetomidine As an Adjuvant to Bupivacaine in Bilateral PECs for Pain Control After Cardiac Surgeries

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

May 31, 2025

Conditions
Post Operative Pain
Interventions
OTHER

bilateral PECS

ectoralis nerve (Pecs) block, which is novel, less invasive regional analgesic technique.

DRUG

Dexmedetomidine

Dexmedetomidine is a potent α2 agonist. In our practice, dexmedetomidine is administered as an additive to regional anesthesia to improve the duration and quality of analgesia

Trial Locations (2)

11954

RECRUITING

Kasralainy school of medicine, Cairo

Unknown

RECRUITING

Kasralaini Faculty of Medicine, Cairo

All Listed Sponsors
lead

Kasr El Aini Hospital

OTHER